Simplex Trading’s Juniper Pharmaceuticals JNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-15,474
Closed -$134K – 8559
2018
Q2
$134K Buy
15,474
+15,235
+6,374% +$137K ﹤0.01% 3954
2018
Q1
$2K Buy
+239
New +$2.01K ﹤0.01% 5475
2017
Q4
– Sell
-1,437
Closed -$6K – 7190
2017
Q3
$6K Buy
+1,437
New +$6.75K ﹤0.01% 4312
2016
Q4
– Sell
-13,330
Closed -$73.2K – 6981
2016
Q3
$73K Buy
13,330
+294
+2% +$1.94K ﹤0.01% 1799
2016
Q2
$91K Buy
13,036
+3,045
+30% +$21.5K 0.01% 1548
2016
Q1
$66K Buy
9,991
+5,086
+104% +$37.4K 0.01% 1720
2015
Q4
$50K Sell
4,905
-5,237
-52% -$60.7K ﹤0.01% 1926
2015
Q3
$119K Buy
10,142
+4,542
+81% +$50.2K 0.01% 1291
2015
Q2
$51K Buy
+5,600
New +$42.3K ﹤0.01% 1695

Simplex Trading's JNP Position: Q3 2018 in Review

Simplex Trading sold out of Juniper Pharmaceuticals (JNP) in Q3 2018, closing a stake of 15,474 shares — an estimated $134K sold.

Simplex Trading first reported a position in JNP in Q2 2015 and held it in 9 quarters. The position peaked at $134K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

  • Simplex Trading reported no remaining Juniper Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Simplex Trading sold 15,474 Juniper Pharmaceuticals shares in Q3 2018, an estimated $134K.
  • Simplex Trading first reported a position in Juniper Pharmaceuticals in Q2 2015 and held it in 9 quarters.
  • Simplex Trading's Juniper Pharmaceuticals position peaked at $134K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals as of Q3 2018.

Based on Simplex Trading's 13F filing for Q3 2018, filed 23 Oct 2018.